Bbva Compass Bancshares Inc. trimmed its holdings in AmerisourceBergen Corp. (NYSE:ABC) by 7.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,882 shares of the company’s stock after selling 2,061 shares during the quarter. Bbva Compass Bancshares Inc.’s holdings in AmerisourceBergen were worth $2,138,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Acima Private Wealth LLC purchased a new stake in shares of AmerisourceBergen in the fourth quarter worth approximately $26,000. Riverview Trust Co raised its holdings in shares of AmerisourceBergen by 127.3% in the first quarter. Riverview Trust Co now owns 391 shares of the company’s stock worth $31,000 after buying an additional 219 shares during the period. Private Capital Group LLC raised its holdings in shares of AmerisourceBergen by 201.3% in the fourth quarter. Private Capital Group LLC now owns 482 shares of the company’s stock worth $36,000 after buying an additional 322 shares during the period. Trust Co. of Vermont raised its holdings in shares of AmerisourceBergen by 963.8% in the first quarter. Trust Co. of Vermont now owns 500 shares of the company’s stock worth $40,000 after buying an additional 453 shares during the period. Finally, JNBA Financial Advisors purchased a new stake in shares of AmerisourceBergen in the fourth quarter worth approximately $37,000. Hedge funds and other institutional investors own 66.61% of the company’s stock.
ABC opened at $77.47 on Friday. The firm has a market cap of $16.28 billion, a price-to-earnings ratio of 11.94, a PEG ratio of 1.54 and a beta of 1.07. AmerisourceBergen Corp. has a 52 week low of $69.36 and a 52 week high of $94.88. The company has a current ratio of 0.95, a quick ratio of 0.56 and a debt-to-equity ratio of 1.43.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings data on Thursday, May 2nd. The company reported $2.11 EPS for the quarter, topping the consensus estimate of $1.96 by $0.15. The company had revenue of $43.32 billion for the quarter, compared to the consensus estimate of $43.44 billion. AmerisourceBergen had a return on equity of 46.24% and a net margin of 0.53%. AmerisourceBergen’s quarterly revenue was up 5.6% on a year-over-year basis. During the same period last year, the business posted $1.94 EPS. On average, equities research analysts forecast that AmerisourceBergen Corp. will post 6.81 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 3rd. Shareholders of record on Monday, May 20th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, May 17th. This represents a $1.60 annualized dividend and a yield of 2.07%. AmerisourceBergen’s payout ratio is currently 24.65%.
Several equities research analysts have recently weighed in on ABC shares. UBS Group started coverage on AmerisourceBergen in a report on Thursday, January 17th. They issued a “buy” rating and a $89.00 price target on the stock. ValuEngine upgraded AmerisourceBergen from a “sell” rating to a “hold” rating in a report on Thursday, January 31st. TheStreet upgraded AmerisourceBergen from a “c+” rating to a “b” rating in a report on Tuesday, February 19th. Zacks Investment Research downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Friday, March 8th. Finally, Wolfe Research started coverage on AmerisourceBergen in a report on Tuesday, April 2nd. They set a “market perform” rating on the stock. Three research analysts have rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $86.57.
In other AmerisourceBergen news, insider Dale Danilewitz sold 5,702 shares of the stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $77.02, for a total transaction of $439,168.04. Following the sale, the insider now owns 8,416 shares of the company’s stock, valued at approximately $648,200.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO James F. Cleary, Jr. bought 2,000 shares of the company’s stock in a transaction on Wednesday, March 6th. The shares were bought at an average cost of $77.52 per share, for a total transaction of $155,040.00. Following the transaction, the chief financial officer now directly owns 7,306 shares in the company, valued at approximately $566,361.12. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 2,018 shares of company stock worth $156,471 and have sold 66,982 shares worth $5,565,339. Company insiders own 27.80% of the company’s stock.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Read More: What is a Tariff?
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.